glp 1 and gallbladder disease Glucagon-like peptide-1 receptor agonist use may up risk for gallbladder, biliary diseases GLP-1 Receptor Agonists: How Safe

Asami Nakata and et

Driessen JHM, van Onzenoort HAW, Henry RMA, Lalmohamed A, van den Bergh JP, Neef C, et al

Most recently in November 2022, Wei and colleagues [82] evaluated mice with T2DM on a high-sugar and high-fat diet for changes in retinal structure following GLP-1RA treatment

Tirzepatide side effects The most common adverse effects of tirzepatide are gastrointestinal: nausea, vomiting, diarrhea, constipation, abdominal pain, and decreased appetite

Because hepatotoxicity is rare after acute overdose, the lack of transaminase elevation following prophylactic carnitine administration does not demonstrate its hepatoprotective properties

J Musculoskelet Res